By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

As the “medicine chest of the world,” New Jersey has brought new life-altering therapies and cures to patients for decades.

Trump's pick for HHS secretary who endured confirmation hearings last week—has repeatedly criticized industry ties to the FDA ...

LinkedIn founder and venture capitalist Reid Hoffman has just launched drug discovery startup Manas AI, alongside Dr.

FDA approves new pain pill Journavx, a non-opioid alternative to treat acute pain. Despite modest effectiveness, it shows promise in pain management.

Since taking office for his second term on Jan. 20, 2025, President Donald Trump has issued a series of executive orders (EOs) aimed at ...

Two USAMRICD researchers have been awarded the federal government’s highest honor for outstanding early career scientists and ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...

Strong IP protections will incentivize the human creativity that’s essential to improving, applying, and using AI.